The permeability transition pore complex:: A target for apoptosis regulation by caspases and Bcl-2-related proteins

被引:582
|
作者
Marzo, I
Brenner, C
Zamzami, N
Susin, SA
Beutner, G
Brdiczka, D
Rémy, R
Xie, ZH
Reed, JC
Kroemer, G
机构
[1] CNRS, Unite Propre Rech 420, F-94801 Villejuif, France
[2] Univ Konstanz, Fac Biol, D-78434 Konstanz, Germany
[3] Univ Paris 11, CNRS, F-91405 Orsay, France
[4] Burnham Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 187卷 / 08期
关键词
D O I
10.1084/jem.187.8.1261
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early in programmed cell death (apoptosis), mitochondrial membrane permeability increases. This is at least in part due to opening of the permeability transition (PT) pore, a multiprotein complex built up at the contact site between the inner aid the outer mitochondrial membranes. The PT pore has been previously implicated in clinically relevant massive cell death induced by toxins, anoxia, reactive oxygen species, and calcium overload. Here we show that PT pore complexes reconstituted in liposomes exhibit a functional behavior comparable with that of the natural PT pore present in intact mitochondria. The PT pore complex is regulated by thiol-reactive agents, calcium, cyclophilin D ligands (cyclosporin A and a nonimmunosuppressive cyclosporin A derivative), ligands of the adenine nucleotide translocator, apoptosis-related endoproteases (caspases), and Bcl-2-like proteins. Although calcium, prooxidants, and several recombinant caspases (caspases 1, 2, 3, 4, and 6) enhance the permeability of PT pore-containing liposomes, recombinant Bcl-2 or Bcl-X-L augment the resistance of the reconstituted PT pore complex to pore opening. Mutated Bcl-2 proteins that have lost their cytoprotective potential also lose their PT modulatory capacity. In conclusion, the PT pore complex may constitute a crossroad of apoptosis regulation by caspases and members of the Bcl-2 family.
引用
收藏
页码:1261 / 1271
页数:11
相关论文
共 50 条
  • [21] The mitochondrial permeability transition pore complex as a pharmacological target. An introduction
    Kroemer, G
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (16) : 1469 - 1472
  • [22] Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-related family proteins
    Wada, T
    Pippin, JW
    Marshall, CB
    Griffin, SV
    Shankland, SJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09): : 2615 - 2625
  • [23] Regulation of mitochondrial membrane premeabilization by BCL-2 family proteins and caspases
    Breckenridge, DG
    Xue, D
    CURRENT OPINION IN CELL BIOLOGY, 2004, 16 (06) : 647 - 652
  • [24] Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore
    Ravagnan, L
    Marzo, I
    Costantini, P
    Susin, SA
    Zamzami, N
    Petit, PX
    Hirsch, F
    Goulbern, M
    Poupon, MF
    Miccoli, L
    Xie, ZH
    Reed, JC
    Kroemer, G
    ONCOGENE, 1999, 18 (16) : 2537 - 2546
  • [25] Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore
    Luigi Ravagnan
    Isabel Marzo
    Paola Costantini
    Santos A Susin
    Naoufal Zamzami
    Patrice X Petit
    François Hirsch
    Marc Goulbern
    Marie-France Poupon
    Laurent Miccoli
    Zhihua Xie
    John C Reed
    Guido Kroemer
    Oncogene, 1999, 18 : 2537 - 2546
  • [26] Regulation of apoptosis by Bcl-2 family proteins
    Burlacu, A
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) : 249 - 257
  • [27] The permeability transition and BCL-2 family proteins in apoptosis: co-conspirators or independent agents?
    M Forte
    P Bernardi
    Cell Death & Differentiation, 2006, 13 : 1287 - 1290
  • [28] The permeability transition and BCL-2 family proteins in apoptosis: co-conspirators or independent agents?
    Forte, M.
    Bernardi, P.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (08): : 1287 - 1290
  • [29] Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis
    Fecker, Lothar F.
    Geilen, Christoph C.
    Tchernev, Georgi
    Trefzer, Uwe
    Assaf, Chalid
    Kurbanov, Bachtier M.
    Schwarz, Constanze
    Daniel, Peter T.
    Eberle, Juergen
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) : 1366 - 1371
  • [30] Bcl-2 related proteins, apoptosis and disease
    Anderson, GP
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (02) : 51 - 51